H.R. 9877
Health Equity and Accountability Act of 2026
Sponsor: Raul Ruiz
26 cosponsors
- Adelita S. Grijalva
- Adriano Espaillat
- Analilia Mejia
- Andrea Salinas
- Ayanna Pressley
- Christian D. Menefee
- Delia C. Ramirez
- Eleanor Holmes Norton
- Emily Randall
- Frederica S. Wilson
- Grace Meng
- Gwen Moore
- Jahana Hayes
- Jesús G. "Chuy" García
- Jill N. Tokuda
- Jonathan L. Jackson
- Judy Chu
- Maxwell Frost
- Nydia M. Velázquez
- Pablo José Hernández
- Pete Aguilar
- Robin L. Kelly
- Shri Thanedar
- Suzanne Bonamici
- Ted Lieu
- Troy A. Carter
Official summary
No official summary yet.
Text of the bill
I Data collection and reporting
II Culturally and linguistically appropriate health and health care
III Health workforce diversity
A Diversifying the health care workplace
B Substance Use Disorder Treatment and Behavioral and Mental Health Workforce
C ACCESS in Mental Health Act
D Developing the Community Health Workforce Act
IV Improving Health Care Access and Quality
A Reducing Barriers to Accessing Care
B Improvement of Coverage
C Expansion of Access
1 General Provisions
2 Rural
3 Indian Communities
4 Providers
5 Dental
D Advancing Health Equity Through Payment and Delivery Reform
E Health Empowerment Zones
F Equitable Health Care for All
G Investing in Equity
H Miscellaneous
I Territories Health Equity
1 Medicare
A Part A
B Part B
C Medicare Advantage (Part C)
D Part D
2 Miscellaneous
V Improving health outcomes for women, gender-diverse people, children, and families
A Underserved communities
B Pregnancy screening
C Pregnancy-Related care
D Federal agency coordination on maternal health
E Reproductive and Sexual Health
F Children’s Health
G Elder Care
H Miscellaneous provisions
VI Mental health and substance use disorders
A Access to care and funding streams
B Interprofessional care
C Workforce development
D Children’s mental health
E Community-Based care
F Reports
G Miscellaneous provisions
VII Addressing high-impact minority diseases
A Cancer
B Viral hepatitis and liver cancer control and prevention
C Acquired bone marrow failure diseases
D Cardiovascular disease, chronic disease, obesity, and other disease issues
E HIV/AIDS
F Diabetes
G Lung disease
H Tuberculosis
I Osteoarthritis and Musculoskeletal Diseases
J Sleep and circadian rhythm disorders
(a) In general. The Director of the Centers for Disease Control and Prevention shall conduct, support, and expand public health strategies and prevention, diagnosis, surveillance, and public and professional awareness activities regarding sleep and circadian rhythm disorders.
(b) Required surveillance and education awareness activities. In conducting or supporting research relating to sleep and circadian rhythm disorders surveillance and education awareness activities, the Director of the Centers for Disease Control and Prevention shall—
(1) ensure that such activities are culturally and linguistically appropriate to minority patients, targeting sleep and circadian rhythm health promotion and prevention programs of each major ethnic group, including—
(A) Native Americans and Alaska Natives;
(B) Asian Americans;
(C) African Americans and Blacks;
(D) Hispanic and Latino-Americans; and
(E) Native Hawaiians and Pacific Islanders;
(2) collect and compile national and State surveillance data on sleep disorders health disparities;
(3) continue to develop and implement new sleep questions in public health surveillance systems to increase public awareness of sleep health and sleep disorders and their impact on health;
(4) publish monthly reports highlighting geographic, racial, and ethnic disparities in sleep health, as well as relationships between insufficient sleep and chronic disease, health risk behaviors, and other outcomes as determined necessary by the Director; and
(5) include public awareness campaigns that inform patient populations from major ethnic groups about the prevalence of sleep and circadian rhythm disorders and emphasize the importance of sleep health.
(c) Authorization of appropriations. To carry out this section, there are authorized to be appropriated such sums as may be necessary for fiscal year 2027 and each subsequent fiscal year.
K Kidney disease research, surveillance, prevention, and treatment
L Diversity in clinical trials
M Additional provisions addressing high-impact minority diseases
N Health Equity and Rare Disease Act
O Asunción Valdivia Heat Illness, Injury, and Fatality Prevention
P New Era of Preventing End-Stage Kidney Disease
VIII Health Information Technology
A Reducing Health Disparities Through Health IT
B Modifications To Achieve Parity in Existing Programs
C Additional Research and Studies
D Closing Gaps in Funding To Adopt Certified EHRs
E Expanding Access to Telehealth Services
IX Accountability and Evaluation
X Addressing Social Determinants and Improving Environmental Justice
A In General
B Gun Violence
C Nutrition for women, children, families
1 Senior hunger prevention
2 Closing the meal gap
D Universal school meals
1 School breakfast program
2 School lunch program
3 Elementary and secondary education data
4 Amendments to other programs and laws
XI Protections to combat regulatory harm to health equity